English English Manufactured in cGMP-compliant cleanroom suites with rigorous HPLC/UV batch-release testing, tailored for dietary supplements, functional foods, and cosmeceuticals.
The biopharmaceutical and nutraceutical corridor traversing Southern Ontario—anchored decisively by the City of Hamilton—is experiencing a major paradigm shift. Historically celebrated as Canada’s industrial steel capital, Hamilton has aggressively diversified into advanced health sciences, biotechnology incubation, and functional nutrition manufacturing. Propelled by world-class medical research infrastructure centered around McMaster University, the McMaster Innovation Park (MIP), and the Synapse Life Science Consortium, local product developers require direct, factory-level access to high-purity active pharmaceutical intermediates. Among these, Beta-Nicotinamide Mononucleotide (β-NMN, CAS 1094-61-7) has emerged as the definitive cellular bio-energetic substrate, driving demand across longevity therapeutics, metabolic optimization, and advanced sports physiology.
Industrial Sourcing Reality: Formulators and contract manufacturing organizations (CMOs) across the Greater Toronto and Hamilton Area (GTHA) cannot afford batch variability, chiral contamination, or chemical solvent residues. Sourcing directly from an established primary synthesis factory guarantees true enzymatic stereo-selectivity, verified active beta-anomer stereospecificity, and full traceability under ISO 9001:2015, ISO 22000, and HACCP parameters.
Pure active β-anomer; zero cytotoxic chemical solvent residues
Engineered for direct capsule filling and precision tablet compression
Stringently compliant with Health Canada NHP monograph limits
SGS-verified production facilities with dual-stage QC batch release
In the Hamilton market, procurement specialists and quality assurance teams face a pivotal technical distinction: the differentiation between fully biological multi-enzyme catalysis and traditional chemical coupling synthesis. Chemical synthesis often relies on organic solvents like acetonitrile, pyridine, and toxic phosphorus halides, which run the risk of generating chemical isomers, notably the inactive or cytotoxic alpha-NMN (α-anomer), alongside persistent heavy metal catalysts.
Our factory utilizes a proprietary, fully closed-loop enzymatic cascade biosynthesis. By mobilizing recombinant nicotinamide phosphoribosyltransferase (NAMPT) and ribokinase systems, the synthesis mirrors endogenous mammalian cellular pathways. This guarantees 100% stereospecificity into the active biological beta-form, yielding a white crystalline powder with crystalline stability, instantaneous aqueous dissolution, and total absence of organic solvent contamination.
| Analytical Parameter | Enzymatic Factory Synthesis (Our Standard) | Generic Chemical Synthesis | Ontario / Health Canada NHP Requirement |
|---|---|---|---|
| Chemical Structure & Isomer | 100% β-Nicotinamide Mononucleotide (Biologically Active) | Mixed α/β isomers requiring harsh chemical fractionation | Pure β-form verified via Chiral HPLC |
| Assay Purity (Dry Basis) | ≥99.5% by HPLC single-peak resolution | 95.0% – 98.0% (frequent degradation peaks) | Minimum ≥98.0% labeled potency |
| Residual Solvents (ICH Q3C) | Zero class 1 & 2 solvents; biological water-phase reaction | Detectable pyridine, methanol, or ethyl acetate | Strict ICH Class 2/3 limits (e.g., Pyridine <200 ppm) |
| Bulk Density Profile | Controlled: Low (0.22 g/mL) to High Density (0.45 g/mL) | Inconsistent, prone to electrostatic clumping | Consistent pourability for automated fill machines |
| Microbiological Bioburden | Total Plate Count <750 CFU/g, Yeast & Mold <50 CFU/g | Variable bioburden depending on crystallization conditions | TPC <1000 CFU/g; Zero Salmonella & E. coli |
| Endotoxin Quantification | <0.05 EU/mg (LAL Test Validated) | Often untested or variable (>0.5 EU/mg) | Crucial for clinical research and bio-absorption |
Aligning raw material specifications with the concrete formulation pipelines of Ontario’s clinical researchers, contract manufacturers, and health brand innovators.
Direct compression into two-piece vegetarian or enteric capsules. Combined with our Sulforaphane Broccoli Sprout Powder to activate synergistic cellular defense via simultaneous NAD+ replenishment and Nrf2 anti-inflammatory pathway induction.
Instantaneous dissolution characteristics allow formulation of rapid-uptake sublingual powders and functional electrolyte recovery beverages, catering to elite athletes and clinical wellness patients across Southern Ontario sports facilities.
Dermal fibroblasts require constant NAD+ pools for DNA repair. Our ultra-pure β-NMN blends seamlessly with Cosmetic Grade PDRN (Salmon DNA) and Pure Vitamin A Powder to create transdermal anti-aging serums for premium Ontario skin clinics.
Providing high-standardization baseline ingredients for biological testing labs around the McMaster health research hub, providing verified molecular identity via 1H-NMR, LC-MS, and independent SGS assay validation.
Entering the Canadian wellness landscape with Nicotinamide Mononucleotide necessitates navigating specific regulatory mechanisms set forth by the Natural and Non-prescription Health Products Directorate (NNHPD) of Health Canada. Brands operating in Hamilton, Burlington, Oakville, and Mississauga seeking to launch finished retail SKUs must obtain an eight-digit Natural Product Number (NPN). Sourcing raw materials from a verified manufacturing facility with comprehensive auditing records simplifies the dossier submission process dramatically.
Every shipment is delivered alongside a comprehensive Certificate of Analysis detailing HPLC retention time, water content (Karl Fischer titration), loss on drying, heavy metals via ICP-MS, and complete bioburden culture data required by Canadian Site Licence holders.
NMN is inherently hygroscopic and susceptible to enzymatic degradation into nicotinamide if exposed to ambient relative humidity (>45% RH). Our factory utilizes triple-laminated medical foil vacuum bags with molecular sieve desiccants to ensure moisture content remains <1.0% throughout transit.
Leveraging Hamilton’s John C. Munro International Airport (YHM)—Canada's primary overnight air cargo gateway—and Toronto Pearson (YYZ), we offer end-to-end CIP, DDP, and expedited air courier deliveries with cleared customs and zero demurrage hold-ups.
Combining 15 years of primary extraction and advanced biosynthesis expertise with audited quality control protocols.
Our manufacturing suites, raw material intake bays, and warehouse operations have been inspected and confirmed onsite by SGS Group, providing buyers with documented supplier validation.
Our comprehensive quality management framework is structured under ISO 9001:2015, ISO 22000, HACCP, HALAL, KOSHER, and FAMI-QS standards, assuring international compliance.
Equipped with state-of-the-art Agilent HPLC systems, UV-Vis spectrophotometers, precision balances, and class-10,000 clean air benches, our in-house lab validates assay, purity, and microbial stability lot by lot.
Beyond raw powder supply, we provide custom formulation blending, tablet punching, capsule filling, and private-label packaging with an export volume surpassing US$4.28M annually.
Addressing core concerns regarding chemical specifications, stability, shipping, and Health Canada documentation.
Connect with our technical application specialists. We supply batch-specific HPLC chromatograms, heavy metal test sheets, bulk tier pricing, and regulatory dossiers tailored for the Canadian market.